84
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Urinary retinol binding protein is a potential biomarker for renal function in primary systemic amyloidosis: A retrospective study

, , , &
Pages 448-450 | Received 01 Feb 2015, Accepted 26 Jun 2015, Published online: 05 Oct 2015

References

  • Merlini G, Comenzo RL, Seldin DC, et al. Immunoglobulin light chain amyloidosis. Expert Rev Hematol 2014;7:143–156.
  • Cuchard P, Cuchard R, Rotman S, et al. Renal amyloidosis. Rev Med Suisse 2012;8:446–451.
  • Ryšavá R. AL Amyloidosis with renal involvement. Kidney Blood Press Res 2007;30:359–364.
  • Dimopoulos MA, Kastritis E, Rosinol L, et al. Pathogenesis and treatment of renal failure in multiple myeloma. Leukemia 2008;22: 1485–1493.
  • Shemesh O, Golbetz H, Kriss JP, et al. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985;28: 830–838.
  • Gavrilov V, Yermiahu T, Gorodischer R. Urinary excretion of retinol in patients with multiple myeloma: a preliminary study. Am J Hematol 2003;74:202–204.
  • Corso A, Serricchio G, Zappasodi P, et al. Assessment of renal function in patients with multiple myeloma: the role of urinary proteins. Ann Hematol 1999;78:371–375.
  • Gertz MA, Comenzo R, Falk RH, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis. Am J Hematol 2005;79: 319–328.
  • Carrie BJ, Golbetz HV, Michaels AS, et al. Creatinine: an inadequate filtration marker in glomerular diseases. Am J Med 1980;69:177–182.
  • Honkanen E, Pettersson T, Teppo AM. Urinary alpha 1- and beta 2-microglobulin in light chain proteinuria. Clin Nephrol 1995;44:22–27.
  • Liu S, Zhai Y, Yu Y, et al. Significance of low molecular weight urinary protein for assessment of early renal damage in patients with multiple myeloma. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2013;21:410–414.
  • Kirsztajn GM, Nishida SK, Silva MS, et al. Urinary retinol-binding protein as a prognostic marker in glomerulopathies. Nephron 2002;90:424–431.
  • Bird J, Cavenagh J, Hawkins P, et al. Guidelines on the diagnosis and management of AL amyloidosis. Br J Haematol 2004;125:681–700.
  • Huang X, Wang Q, Jiang S, et al.The clinical features and outcomes of systemic AL amyloidosis: a cohort of 231 Chinese patients. Clin Kidney J 2015;8:120–126.
  • Hemminger J, Satoskar A, Brodsky SV, et al. Unique pattern of renal κ light chain amyloid deposition with histiocytic transdifferentiation of tubular epithelial cells. Am J Surg Pathol 2012;36:1253–1257.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.